Fast Five Quiz: Pneumococcal Infections

Jocelyn Y. Ang, MD


September 15, 2021

The CDC recommends routine administration of PPSV23 for all adults 65 years and older. The CDC also recommends administration of PCV13 based on shared decision-making for adults 65 years and older who do not have an immunocompromising condition, cerebrospinal fluid leak, or cochlear implant, and who have never received a dose of PCV13.

Any patient who has received a dose of PPSV23 before age 65 should receive one final dose of the vaccine when they are 65 years or older. This last dose should be administered at least 5 years after the prior PPSV23 dose.

Learn more about pneumococcal vaccines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.